Oncology remains the most dynamic and fastest-growing therapeutic area in clinical research. Nearly 40% of all clinical trials initiated in recent years have targeted oncology,

In rare disease studies, enrollment is not simply a logistical hurdle — it’s a human endeavor. Behind every data point is a patient who has

Too often, sponsors facing enrollment challenges in specific regions are forced into a false choice: accept the delay or close the country. But there’s a

The past two years have been a sobering period for the biotechnology industry. After the record-breaking highs of 2020 and 2021, the market has shifted

At Confidence Pharmaceutical Research, we know that the strength of our work comes from the people behind it. This month, we’re shining a spotlight on

Clinical development in rare and orphan indications is often defined by urgency, unmet need, and an extraordinary level of complexity. While scientific innovation continues to

The landscape of biotech innovation is no longer confined to traditional strongholds like Boston, San Diego, or Basel. While these regions continue to lead in

Clinical trials involve many moving parts—protocol design, site performance, patient engagement, regulatory timelines, vendor coordination. While strong planning is essential, missed milestones often trace back

At Confidence Pharmaceutical Research, delivering smarter, faster, and more reliable feasibility assessments is critical to ensuring clinical trial success. Vassily Gnedovsky, our Director of Feasibility

In a world where every second counts for patients with life-threatening conditions, the U.S. Food and Drug Administration’s (FDA) Accelerated Approval pathway offers a lifeline.

Recruiting participants for clinical trials remains one of the most challenging aspects of research. While modern strategies such as digital outreach and decentralized trials have

In the fast-paced world of clinical trials, site selection is one of the most important factors contributing to a study’s success, working in tandem with